HSPA4 and pancreatic neoplasm: The overexpression of the latter enhances cisplatin sensitivity in osteosarcoma, while the upregulation of miR-142-3p in pancreatic cancer cells inhibits proliferation by targeting HSPA4 (HSP70) (187).